IHS Chemical Week

Regions :: Western Europe :: Belgium

Solvay Shareholder Denies Approach from Sanofi-Aventis

10:33 AM MDT | April 2, 2009 | Natasha Alperowicz

Solvac (Brussels), the family owned holding vehicle, which controls 30.07% in Solvay, has denied press reports that it has been approached about the potential sale of Solvay's pharmaceuticals business. "Solvac denies any contact with third parties about the sale of its participation in Solvay, in part or in total," the company said today. A report in the Financial Times stated that Sanofi-Aventis has made a direct approach to Solvac but that Solvac rejected the offer, which valued the whole company at €7.2 billion ($9.6...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.


Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis from the entire global chemical enterprise on chemweek.com
  • Mobile edition of Chemical Week
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional focus
  • Global outlook issue

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa